Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:HIV-2
|
| gptkbp:catch_rate |
vary by region
|
| gptkbp:caused_by |
gptkb:healthcare_organization
|
| gptkbp:clinical_trial |
in progress
|
| gptkbp:community_involvement |
important for education
|
| gptkbp:complications |
can occur
|
| gptkbp:cultural_practices |
associated with infection
|
| gptkbp:data_usage |
high in endemic areas
|
| gptkbp:discontinued |
can transmit virus
|
| gptkbp:disease_resistance |
liver cancer
cirrhosis |
| gptkbp:duration |
varies
|
| gptkbp:education |
important for prevention
|
| gptkbp:first_flight |
lipid envelope
|
| gptkbp:healthcare |
gptkb:Centers_for_Disease_Control_and_Prevention
at risk important issue impact prevention efforts |
| https://www.w3.org/2000/01/rdf-schema#label |
HBV
|
| gptkbp:influenced_by |
can help manage infection
|
| gptkbp:is_adopted_by |
possible treatment
|
| gptkbp:is_involved_in |
available for patients
|
| gptkbp:is_monitored_by |
liver function tests
viral load |
| gptkbp:is_protected_by |
vaccination
|
| gptkbp:is_vulnerable_to |
gptkb:HBV_vaccine
high |
| gptkbp:metabolism |
used for assessment
|
| gptkbp:public_awareness |
needed for prevention
|
| gptkbp:publishes |
in hepatocytes
|
| gptkbp:research |
ongoing for better treatments
|
| gptkbp:risk_factor |
sharing needles
multiple sexual partners unprotected sex healthcare exposure |
| gptkbp:scientific_classification |
gptkb:World_Health_Organization
|
| gptkbp:screenings |
recommended for high-risk groups
|
| gptkbp:seed_dispersal |
circular DNA
|
| gptkbp:social_responsibility |
gptkb:HCV
gptkb:HIV possible blood test global prevalence long-term consequences requires lifelong management important in healthcare settings |
| gptkbp:symptoms |
fatigue
abdominal pain jaundice |
| gptkbp:tactics |
elimination by 2030
|
| gptkbp:transmission |
gptkb:healthcare_organization
sexual contact mother to child higher during acute phase |
| gptkbp:treatment |
gptkb:stock_market_index
antiviral medications viral suppression can reduce liver damage |
| gptkbp:warranty |
recommended for chronic patients
|
| gptkbp:was_marked_by |
H Bs Ag
anti-H Bc anti-H Bs |